{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:04:23Z","timestamp":1794434663704,"version":"4.9.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The incidence of leptomeningeal metastasis (LM) is underestimated because of its non-specific signs and the low sensitivity of clinical diagnostic modalities. Cerebrospinal magnetic resonance (MR) imaging with and without contrast enhancement (CE) is a gold standard for the neuroradiological assessment of patients with suspected LM. Previous studies suggested that some LM cases show changes of the brainstem surface on non-contrast MR images without or before the appearance of abnormalities on CE images. We assessed the features of this non-contrast MR finding in a cohort of LM patients in this retrospective single-institution study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We reviewed head MR images and clinical data of 142 consecutive patients in whom the final diagnosis was LM.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We found that 11 of these 142 patients (7.7%) with LM had band-like hyperintensity on the brainstem surface on non-enhanced FLAIR images, which looked like bloomy rind on cheese. Three of seven patients who were examined using diffusion-weighted imaging showed restricted diffusion in the corresponding lesion site. The above-mentioned 11 patients included 10 women and 1 man, with a median age of 61\u2009years. All 11 patients had primary lung adenocarcinoma. Seven patients had symptomatic hydrocephalus. Ten patients had EGFR-mutated and one had ALK-rearrangement adenocarcinomas. Before the diagnosis of LM, 10 patients had undergone systemic therapy with EGFR-TKI or pemetrexed, and 1 patient with ALK inhibitor and bevacizumab.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We present a series of patients with bloomy rind sign that is non-enhancing LM reliably detected by FLAIR hyperintensity on the brainstem surface. This finding is rare, but may reflect the spread of cancer cells in both the leptomeningeal membrane and the surface of the brain parenchyma specifically in patients with lung adenocarcinomas. Further study is needed to determine the clinical significance of this sign, and the pathophysiological factors associated with it may be clarified by analyzing serial MR images in a larger cohort of patients treated for LM.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40644-020-00361-8","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T15:10:21Z","timestamp":1606144221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-5427","authenticated-orcid":false,"given":"Koichi","family":"Mitsuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nakasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Shirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koiku","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakamasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"361_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nec.2010.08.006","volume":"22","author":"MD Groves","year":"2011","unstructured":"Groves MD. Leptomeningeal disease. Neurosurg Clin N Am. 2011;22:67\u201378.","journal-title":"Neurosurg Clin N Am"},{"issue":"suppl 4","key":"361_CR2","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Rud\u00e0 R, Preusser M. EANO executive board and ESMO guidelines committee: EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol. 2017;28(suppl 4):iv84\u201399.","journal-title":"Ann Oncol"},{"key":"361_CR3","first-page":"535","volume":"23","author":"JH Lee","year":"2002","unstructured":"Lee JH, Na DG, Choi KH, Kim KJ, Ryoo JW, Lee SY, Suh YL. Subcortical low intensity on MR images of meningitis, viral encephalitis, and leptomeningeal metastasis. AJNR Am J Neuroradiol. 2002;23:535\u201342.","journal-title":"AJNR Am J Neuroradiol"},{"key":"361_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1552-6569.2009.00389.x","volume":"21","author":"S Karimi","year":"2011","unstructured":"Karimi S, Lis E, Gilani S, D\u2019Ambrosio N, Holodny A. Nonenhancing brain metastases. J Neuroimaging. 2011;21:184\u20137.","journal-title":"J Neuroimaging"},{"key":"361_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.jocn.2011.12.029","volume":"19","author":"I Ayzenberg","year":"2012","unstructured":"Ayzenberg I, B\u00f6rnke C, T\u00f6nnes C, Ziebarth W, Lavrov A, Lukas C. Extensive cortical involvement in leptomeningeal carcinomatosis. J Clin Neurosci. 2012;19:1723\u20135.","journal-title":"J Clin Neurosci"},{"key":"361_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neurad.2014.05.003","volume":"41","author":"A Crombe","year":"2014","unstructured":"Crombe A, Alberti N, Durieux M, Frulio N, Dousset V, Tourdias T. Exceptional symmetric anterior brainstem involvement in leptomeningeal carcinomatosis. J Neuroradiol. 2014;41:279\u201381.","journal-title":"J Neuroradiol"},{"key":"361_CR7","doi-asserted-by":"publisher","first-page":"e1053","DOI":"10.1097\/MD.0000000000001053","volume":"94","author":"EK Khil","year":"2015","unstructured":"Khil EK, Lee AL, Chang KH, Yun TJ, Hong HS. Symmetrical curvilinear cytotoxic edema along the surface of the brainstem: A probable new magnetic resonance imaging finding of leptomeningeal carcinomatosis. Medicine (Baltimore). 2015;94:e1053.","journal-title":"Medicine (Baltimore)"},{"key":"361_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/1941874415591702","volume":"6","author":"V Hatzoglou","year":"2016","unstructured":"Hatzoglou V, Karimi S, Diamond EL, Lis E, Krol G, Holodny AI, Young RJ. Nonenhancing leptomeningeal metastases: imaging characteristics and potential causative factors. Neurohospitalist. 2016;6:24\u20138.","journal-title":"Neurohospitalist"},{"key":"361_CR9","doi-asserted-by":"crossref","unstructured":"Cheng CY, Hsu CY, Tsai YH, Lin KL, Huang CE, Fan YH, Chin SC, Huang YC. Novel anterior brainstem magnetic resonance imaging findings in non-small cell lung cancer with leptomeningeal carcinomatosis. Front Neurol. 2017;8:\u2013579.","DOI":"10.3389\/fneur.2017.00579"},{"key":"361_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2169\/internalmedicine.1469-18","volume":"58","author":"K Maeda","year":"2019","unstructured":"Maeda K, Wada H, Ozaki Y, Inoue A. Symmetric ventral brainstem lesion in leptomeningeal carcinomatosis. Intern Med. 2019;58:759\u201360.","journal-title":"Intern Med"},{"key":"361_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/neuonc\/now197","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Junck L, Brandsma D, Soffietti R, Rud\u00e0 R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA. Leptomeningeal metastases: a RANO proposal for response criteria. Neuro-Oncology. 2017;19:484\u201392.","journal-title":"Neuro-Oncology"},{"key":"361_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1148\/radiology.217.1.r00oc3550","volume":"217","author":"SK Singh","year":"2000","unstructured":"Singh SK, Agris JM, Leeds NE, Ginsberg LE. Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology. 2000;217:50\u20133.","journal-title":"Radiology."},{"key":"361_CR13","first-page":"817","volume":"23","author":"SK Singh","year":"2002","unstructured":"Singh SK, Leeds NE, Ginsberg LE. MR imaging of leptomeningeal metastases: comparison of three sequences. AJNR Am J Neuroradiol. 2002;23:817\u201321.","journal-title":"AJNR Am J Neuroradiol"},{"key":"361_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11060-009-9969-2","volume":"96","author":"BK Kleinschmidt-DeMasters","year":"2010","unstructured":"Kleinschmidt-DeMasters BK, Damek DM. The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis. J Neuro-Oncol. 2010;96:375\u201384.","journal-title":"J Neuro-Oncol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-020-00361-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T15:56:46Z","timestamp":1606147006000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-020-00361-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1186\/s40644-020-00361-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this study was obtained from ethical review board of Shizuoka Cancer Center. Individual written informed consent was waived because this study was retrospective in design and based on database extracted records. The waivers of participant consent were approved by the ethical review boards of Shizuoka Cancer Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}